An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is ...

Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s BNT-327 in a deal possibly worth over $11 ...

The U.S. FDA’s decision to grant breakthrough device designation for Bivacor Inc.’s titanium total artificial heart (TAH) ...

Shares of Lyra Therapeutics Inc. soared more than 310% on data from its second phase III trial testing drug-device candidate ...

Despite the advancement of AI and machine learning technologies and their incorporation into cancer treatment and drug ...

Biopharma’s nonprofit deal and grant activity continues to settle into a post-pandemic rhythm, with both showing a sustained ...

More phase III data coursed through the annual American Society of Clinical Oncology (ASCO) conference on Sunday, as ...

Several 5-HT4 receptor (5-HT4R) agonists are approved for treating chronic idiopathic constipation (CIC) by stimulating ...

The polarization of macrophages is crucial in modulating the tumor microenvironment and impacting cancer development. Long ...

Bronchodilators are front-line weapons against asthma and chronic obstructive pulmonary disorder. The search continues for ...

The Trump administration released its budget proposal for fiscal year 2026, which would chop roughly 40% from the NIH budget ...

Samsung Medical Center spinoff Aimedbio Inc. announced raising ₩51.1 billion (US$37.15 million) in pre-IPO funding to advance its portfolio of clinical and preclinical antibody-drug conjugate (ADC) ...